Back to Search

Antihemophilic Factor (Recombinant) Fc Fusion Protein (Efmoroctocog alfa) – Uses, Dosage, and Brands in UAE

Brand Name: ELOCTA
Strength: 1500 IU | Form: Powder For Solution For Intravenous Injection
Price in UAE: AED 5256.50
Available in UAE pharmacies

About Antihemophilic Factor (Recombinant) Fc Fusion Protein (Efmoroctocog alfa)

Class: | Hemostatic agent, Factor VIII replacement therapy Use: | Treatment and prophylaxis of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency) Adult dose: | 50 IU/kg body weight for on-demand treatment; 20-40 IU/kg every 3-5 days for prophylaxis, adjusted based on clinical response Pediatric dose: | 50 IU/kg for on-demand treatment; 20-40 IU/kg every 3-5 days for prophylaxis, adjusted based on clinical response; dosing may vary based on age and weight

Drug Class

Hemostatic agent, Factor VIII replacement therapy

Uses & Indications

Treatment and prophylaxis of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency)

Storage Requirements

Store in a refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; may be stored at room temperature (up to 25°C or 77°F) for a maximum of 3 months

Manufacturer & Packaging

Manufacturer: Swedish Orphan Biovitrum AB, SWEDEN

Package Size

1 Glass Vial+ 1 Pre-filled Syringe (5 ml Solvent) + 1 Plunger Rod + 1 Vial Adapter + 1 Infusion Set + 2 Swabs + 2 Plasters + 1 Gauze

Price & Supplier

Price in UAE: AED 5256.50

Dosage Information

Adult Dose

50 IU/kg body weight for on-demand treatment; 20-40 IU/kg every 3-5 days for prophylaxis, adjusted based on clinical response

Pediatric Dose

50 IU/kg for on-demand treatment; 20-40 IU/kg every 3-5 days for prophylaxis, adjusted based on clinical response; dosing may vary based on age and weight

Side Effects

Headache, nausea, infusion site reactions, arthralgia, and fever

Contraindications & Precautions

Known hypersensitivity to Efmoroctocog alfa or any component of the formulation; history of severe allergic reactions to factor VIII products

Important Warnings

Risk of thrombosis and thromboembolic events; monitor for signs of allergic reactions; patients with inhibitors to factor VIII may not respond to treatment; use caution in patients with cardiovascular disease or risk factors for thrombosis

Other Brands & Strengths Available in UAE

Different brands and strengths of Antihemophilic Factor (Recombinant) Fc Fusion Protein (Efmoroctocog alfa) available in UAE pharmacies:

ELOCTA 1000 IU Powder For Solution For Intravenous Injection ELOCTA 1500 IU Powder For Solution For Intravenous Injection ELOCTA 2000 IU Powder For Solution For Intravenous Injection ELOCTA 2000 IU Powder For Solution For Intravenous Injection ELOCTA 250 IU Powder For Solution For Intravenous Injection ELOCTA 3000 IU Powder For Solution For Intravenous Injection ELOCTA 500 IU Powder For Solution For Intravenous Injection

Related Medicines in Same Category

See also: Other Hemostatic agent, Factor VIII replacement therapy medicines available in UAE pharmacies

Antihemophilic Factor (Recombinant) Fc Fusion Protein Antihemophilic Factor (Recombinant) Fc Fusion Protein

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

View All Hemostatic agent, Factor VIII replacement therapy Medicines Browse All Categories